Immune Activation in Patients With Irritable Bowel Syndrome

Slides:



Advertisements
Similar presentations
Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.
Advertisements

Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis  Alexander C. Ford, Brennan M.R. Spiegel, Nicholas.
Postinfectious Irritable Bowel Syndrome
A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
Volume 149, Issue 6, Pages e2 (November 2015)
Volume 145, Issue 4, Pages (October 2013)
Prevalence, Characteristics, and Impact of Bloating Symptoms in Patients With Irritable Bowel Syndrome  Yehuda Ringel, Rachel E. Williams, Linda Kalilani,
Volume 128, Issue 3, Pages (March 2005)
Volume 144, Issue 5, Pages e3 (May 2013)
Volume 129, Issue 5, Pages (November 2005)
Volume 152, Issue 4, Pages (March 2017)
Christoph Lübbert, Babett Holler  Gastroenterology 
Covering the Cover Gastroenterology
Functional Gastroduodenal Disorders
Volume 145, Issue 6, Pages e1 (December 2013)
Volume 133, Issue 5, Pages (November 2007)
Covering the Cover Gastroenterology
Is HCV Infection a Neurologic Disorder?
Outcomes Among Living Liver Donors
Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection  Tobias Boettler, Robert Thimme  Gastroenterology 
Immune Reconstitution Inflammatory Syndrome of the Small Bowel in a Human Immunodeficiency Virus–Negative Patient  Severin Daum, Christoph Loddenkemper,
Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis  Anita Sainsbury, David S. Sanders, Alexander C.
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 141, Issue 5, Pages (November 2011)
Effect of Peptide YY3–36 on Food Intake in Humans
Volume 149, Issue 6, Pages e2 (November 2015)
A Diet Low in Fermentable Oligo-, Di-, and Monosaccharides and Polyols Improves Quality of Life and Reduces Activity Impairment in Patients With Irritable.
A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
Covering the Cover Gastroenterology
The Changing Liver Transplant Waitlist: An Emerging Liver Purgatory?
Volume 149, Issue 6, Pages e2 (November 2015)
Volume 133, Issue 3, Pages e1 (September 2007)
Volume 150, Issue 4, Pages (April 2016)
Volume 150, Issue 4, Pages (April 2016)
Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis  Alexander C. Ford, Brennan M.R. Spiegel, Nicholas.
Mood and Anxiety Disorders Precede Development of Functional Gastrointestinal Disorders in Patients but Not in the Population  Michael P. Jones, Jan Tack,
Carol S. North, Dana Downs, Ray E. Clouse, Aydamir Alrakawi, Mehmet E
Volume 151, Issue 6, Pages (December 2016)
Volume 149, Issue 2, Pages e2 (August 2015)
Efficient Early Drug Development for Ulcerative Colitis
Michael Camilleri, Allen W. Mangel, Sheri E. Fehnel, Douglas A
Volume 153, Issue 4, Pages (October 2017)
Kara Bradford, Wendy Shih, Elizabeth J. Videlock, Angela P
Melena and Hyperammonemic Seizures in a Turner Syndrome Patient
Bowel Urgency in Patients With Irritable Bowel Syndrome
Volume 138, Issue 1, Pages (January 2010)
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Rebecca M. Lovell, Alexander C. Ford 
Maria Rescigno, Iliyan D. Iliev  Gastroenterology 
Volume 148, Issue 3, Pages (March 2015)
Covering the Cover Gastroenterology
Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome  Lilian Dindo, PhD  Clinical Gastroenterology.
The Rise and Fall (and Rise?) of Endoscopic Anti-Reflux Procedures
Systematic Review and Meta-analysis of the Prevalence of Irritable Bowel Syndrome in Individuals With Dyspepsia  Alexander C. Ford, Avantika Marwaha,
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
Volume 151, Issue 4, Pages (October 2016)
Volume 156, Issue 4, Pages (March 2019)
Covering the Cover Gastroenterology
Postinfectious Irritable Bowel Syndrome
Volume 156, Issue 4, Pages (March 2019)
David J. Gracie, Elspeth A. Guthrie, P. John Hamlin, Alexander C. Ford 
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Quantitative Meta-analysis Identifies Brain Regions Activated During Rectal Distension in Irritable Bowel Syndrome  Kirsten Tillisch, Emeran A. Mayer,
Volume 133, Issue 4, Pages (October 2007)
Volume 139, Issue 1, Pages (July 2010)
Bowel Urgency in Patients With Irritable Bowel Syndrome
Coping Strategies and Interpersonal Support in Patients With Irritable Bowel Syndrome and Inflammatory Bowel Disease  Michael P. Jones, Sarah Wessinger,
Covering the Cover Gastroenterology
Presentation transcript:

Immune Activation in Patients With Irritable Bowel Syndrome Tobias Liebregts, Birgit Adam, Christoph Bredack, Alexander Röth, Susanne Heinzel, Sue Lester, Sarah Downie–Doyle, Eric Smith, Paul Drew, Nicholas J. Talley, Gerald Holtmann  Gastroenterology  Volume 132, Issue 3, Pages 913-920 (March 2007) DOI: 10.1053/j.gastro.2007.01.046 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 (A) TNF-α production (pg/mL) by PBMCs from HCs and IBS patients before (baseline) and (B) after stimulation with 1 ng/mL of E coli LPS. The boxed area represents the interquartile range of HCs. Under baseline conditions, subjects with D-IBS showed significantly (P < .05) higher TNF-α levels compared with HCs. LPS co-incubation caused a significant increase of TNF-α in all subjects compared with nonstimulated PBMCs. The LPS-induced TNF-α production was significantly (P = .005) higher in D-IBS patients compared with HCs. No significant differences were observed in M-IBS and C-IBS, whereas PI-IBS showed significantly higher baseline and LPS-stimulated TNF-α levels compared with HCs. Patients with PI-IBS did not differ significantly from patients with D-IBS. Gastroenterology 2007 132, 913-920DOI: (10.1053/j.gastro.2007.01.046) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 (A) IL-1β production (pg/mL) by PBMCs from HCs and IBS patients before (baseline) and (B) after stimulation with 1 ng/ml of E coli LPS. The boxed area represents the interquartile range of HCs. Under baseline conditions, subjects with D-IBS showed significantly (P = .004) higher IL-1β levels compared with HCs. Co-incubation with LPS significantly enhanced IL-1β production in all subjects compared with baseline. The LPS-induced increase of IL-1β was significantly higher in D-IBS (P = .01) and C-IBS (P = .012) patients compared with HCs, whereas there were no significant alterations in M-IBS. PI-IBS patients showed significantly (P < .05) higher baseline and LPS-induced IL-1β levels compared with HCs without a significant difference vs D-IBS. Gastroenterology 2007 132, 913-920DOI: (10.1053/j.gastro.2007.01.046) Copyright © 2007 AGA Institute Terms and Conditions

Figure 3 (A) IL-6 production (pg/mL) by PBMCs from HCs and IBS patients before (baseline) and (B) after stimulation with 1 ng/mL of E coli LPS. The boxed area represents the interquartile range of HCs. Compared with controls, baseline (P = .005) and LPS-stimulated (P = .011) IL-6 production was significantly higher in D-IBS and (P < .05) PI-IBS patients. There were no significant differences in M-IBS and C-IBS. Gastroenterology 2007 132, 913-920DOI: (10.1053/j.gastro.2007.01.046) Copyright © 2007 AGA Institute Terms and Conditions

Figure 4 Correlation of E coli LPS-induced TNF-α production (pg/mL) and anxiety scores assessed by the Hospital Anxiety and Depression Scale. A score of 11 or greater is considered indicative of an anxiety disorder. Overall, LPS-induced TNF-α release is associated significantly with anxiety scores (r = 0.59, P < .001) in patients with IBS, although it did not reach statistical significance for the IBS subgroups (M-IBS: r = 0.26, P = .30; C-IBS: r = 0.31, P = .17; D/PI-IBS: r = 0.45, P = .14). ●, M-IBS; ○, C-IBS; ▼, D-IBS; Δ, PI-IBS. Gastroenterology 2007 132, 913-920DOI: (10.1053/j.gastro.2007.01.046) Copyright © 2007 AGA Institute Terms and Conditions